View Latest Medical and Pharma Bids and Tenders

Advanced Search

Norway immunoglobulin Tenders Contracts and Bids

Find Norway immunoglobulin tenders and government contracts. Search business opportunities for Norway immunoglobulin tenders..

Similar tenders from other countries

Summary:
Open House Biologics Discount Agreements 2024-11 - Hepatitis B Immunoglobulin (Atc Code J06Bb04)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Oct 2026
Posting Date:
23 Sep 2024
 
 
 
Summary:
Open House Biologics Discount Agreements 2024-11 - Hepatitis B Immunoglobulin (Atc Code J06Bb04)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Oct 2026
Posting Date:
23 Sep 2024
 
 
 
Summary:
Open House Biologics Discount Agreements 2024-11 - Hepatitis B Immunoglobulin (Atc Code J06Bb04)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Oct 2026
Posting Date:
23 Sep 2024
 
 
 
Summary:
Supplies Of Medicinal Products
Country:
Poland
 
Notice Type:
Tender Notice
Deadline:
25 Oct 2025
Posting Date:
11 Oct 2025
 
 
 
Summary:
Supply of Sodium Heparin (DOE), Multivitamins without minerals for parenteral use, Antid Immunoglobulin (DOE), Temozolomide (DOE) and Quetiapine (DOE)
Country:
Spain
Estimated Cost:
EUR 753774
Notice Type:
Tender Notice
Deadline:
24 Oct 2025
Posting Date:
11 Oct 2025
 
 
 
Summary:
Object: Electronic Auction - Price Registration For Acquisition Of Miscellaneous And Oncological Medicines, For Santa Maria University Hospital (Husm-Ufsm)
Country:
Brazil
 
Notice Type:
Tender Notice
Deadline:
25 Oct 2025
Posting Date:
11 Oct 2025
 
 
 
Summary:
Delivery Of Medicinal Preparations (Drugs From Drug And Chemotherapy Programs, General Hospital Drugs)
Country:
Poland
 
Notice Type:
Tender Notice
Deadline:
25 Oct 2025
Posting Date:
10 Oct 2025
 
 
 
Summary:
Procurement Of Medicines Consenting Medicines In Hospital Health Care Facilities That Are Financed From The Fundamental Fund Of Solidarity, Namely: Immunosuppressants, Medicines For The Treatment Of Hepatitis C And B, Drugs For The Treatment Of Multiple Sclerosis, Medicines For The Treatment Of Hemophilia, Humane Immunolobulin, Biological Drugs For The Treatment Of Inflamed Colon. (Rsv) Of Endangered Groups Of Children Palivizumab In F Bih Et Al. Iii
Country:
Bosnia and Herzegovina
 
Notice Type:
Tender Notice
Deadline:
25 Oct 2025
Posting Date:
10 Oct 2025
 
 
 
Summary:
Monoclonal Antibody - Dupilumab I.
Country:
Czech Republic
Estimated Cost:
EUR 8800000
Notice Type:
Tender Notice
Deadline:
11 Nov 2025
Posting Date:
09 Oct 2025
 
 
 
Summary:
Supply Of Heparin Sodium (Doe), Multivitamins Without Minerals For Parenteral Use, Anti-D Immunoglobulin (Doe), Temozolomide (Doe) And Quetiapine (Doe)
Country:
Spain
 
Notice Type:
Tender Notice
Deadline:
24 Oct 2025
Posting Date:
09 Oct 2025